May 9 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. http://on.wsj.com/2pWooqD- PTC Therapeutics Inc said Monday it would receive a net price of $35,000 annually per patient for Emflaza, the muscular dystrophy drug it acquired from Marathon Pharmaceuticals LLC last month. http://on.wsj.com/2pWrqLf- Coach Inc agreed to acquire rival Kate Spade & Co for $2.4 billion, as the handbag and accessories maker seeks to tap younger consumers amid slower growth in the handbag market. http://on.wsj.com/2pWsHlw- Goldman Sachs Group Inc promoted deal maker Gregg Lemkau and financing executive Marc Nachmann to join John Waldron as co-heads of the investment-banking division, according to people familiar with the matter.

Source: Wall Street Journal May 09, 2017 06:56 UTC